Key Events This Week
7 Sep: MarketsMOJO upgrades Granules India Ltd to Buy rating
8 Sep: Technical momentum shifts signal bullish outlook
11 Sep: Stock hits new 52-week high at Rs.913.8 and all-time high at Rs.913.20
11 Sep: High-value trading amid slight price dip
7 September: Upgrade to Buy Rating Spurs Early Week Gains
Granules India Ltd began the week on a strong note, closing at Rs.866.65, up 2.25% from the previous Friday’s close of Rs.847.60. This surge followed MarketsMOJO’s upgrade of the stock from Hold to Buy on 7 September 2026, reflecting improved technical indicators and robust financial metrics. The company’s Mojo Score rose to 72.0, signalling increased investor confidence.
The upgrade was supported by Granules India’s strong management efficiency, with a Return on Capital Employed (ROCE) of 16.82%, and a conservative Debt to EBITDA ratio of 1.28 times. Financial results showed net sales of ₹1,476.77 crores for Q1 FY26-27 and a 41.39% increase in profit after tax over six months, underscoring operational strength. Despite a modest operating profit growth rate of 6.31% annually over five years, the company’s valuation remains attractive relative to peers, with a PEG ratio of 1.
8 September: Technical Momentum Shift Reinforces Bullish Outlook
The stock extended gains on 8 September, closing at Rs.896.25, a 3.42% increase on the day, even as the Sensex declined 0.21%. Technical indicators shifted from mildly bullish to bullish, supported by positive daily moving averages and bullish Bollinger Bands on weekly and monthly charts. While weekly MACD and Know Sure Thing (KST) oscillators showed mild bearishness, monthly readings were bullish, suggesting strengthening medium- to long-term momentum.
Granules India’s year-to-date return of 44.79% and one-year return of 69.62% starkly outpaced the Sensex’s negative returns, highlighting the stock’s resilience. Institutional investors increased their holdings by 1.29% in the previous quarter, further signalling confidence in the company’s prospects.
Our latest monthly pick, this Small Cap from Oil Exploration/Refineries, is showing strong performance since announcement! See why our Investment Committee chose it after screening 50+ candidates.
- - Investment Committee approved
- - 50+ candidates screened
- - Strong post-announcement performance
9 September: Minor Pullback Amid Broader Market Weakness
On 9 September, Granules India Ltd experienced a slight correction, closing at Rs.883.20, down 1.46% from the previous day’s close. This dip coincided with a sharper Sensex decline of 0.62%, reflecting broader market weakness. The stock’s volume remained healthy, indicating sustained investor interest despite the pullback.
This minor setback did not alter the overall bullish technical outlook, as the stock continued to trade above key moving averages and maintained strong institutional support.
10 September: Recovery and Continued Uptrend
The stock rebounded on 10 September, closing at Rs.901.50, a 2.07% gain, while the Sensex marginally declined by 0.03%. The recovery was supported by positive technical signals and steady volume, reinforcing the stock’s resilience. Granules India remained well-positioned above its 5-day, 20-day, and 50-day moving averages, signalling sustained upward momentum.
11 September: New 52-Week and All-Time Highs Amid High-Value Trading
Granules India Ltd reached a new 52-week high of Rs.913.80 and an all-time high of Rs.913.20 on 11 September 2026, marking a significant milestone. Despite an intraday low of Rs.880.75, the stock closed at Rs.909.65, up 0.90% on the day, outperforming the Sensex which fell 0.39%. This achievement reflected strong financial fundamentals, including a ROCE of 16.82%, a low Debt to EBITDA ratio of 1.28, and a 41.39% PAT growth over six months.
Trading activity was notably robust, with a total volume of 25,49,720 shares and a traded value of ₹22,869.46 lakhs, placing Granules India among the most actively traded equities by value. Although the stock experienced a slight price dip intraday, it maintained technical strength by trading above all key moving averages, indicating sustained bullish momentum.
Get the full story on Granules India Ltd! Our detailed research dives into fundamentals, sector comparison, technical analysis, and valuations for this small-cap. Make informed decisions!
- - Full research story
- - Sector comparison done
- - Informed decision support
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-09-07 | Rs.866.65 | +2.25% | 36,218.97 | -0.46% |
| 2026-09-08 | Rs.896.25 | +3.42% | 36,144.32 | -0.21% |
| 2026-09-09 | Rs.883.20 | -1.46% | 35,921.77 | -0.62% |
| 2026-09-10 | Rs.901.50 | +2.07% | 35,912.77 | -0.03% |
| 2026-09-11 | Rs.909.65 | +0.90% | 35,773.24 | -0.39% |
Key Takeaways
Granules India Ltd’s 7.32% weekly gain amid a 1.68% decline in the Sensex highlights its strong relative performance and resilience. The MarketsMOJO upgrade to a Buy rating on 7 September was a pivotal catalyst, reflecting improved technical and fundamental metrics. The stock’s technical momentum shifted decisively bullish, supported by daily moving averages and Bollinger Bands, despite some mild bearishness in weekly oscillators.
Financially, the company demonstrated robust growth with a 41.39% increase in PAT over six months and a strong ROCE of 16.82%. Institutional investors increased their stake, signalling confidence. The achievement of new 52-week and all-time highs on 11 September further validated the stock’s upward trajectory.
However, the modest annualised operating profit growth of 6.31% over five years and relatively high valuation multiples suggest measured expectations. The slight dip in delivery volume and minor price pullbacks during the week indicate potential short-term volatility, warranting close monitoring.
Conclusion
Granules India Ltd’s week was marked by significant positive developments, including a rating upgrade, technical momentum shifts, and record price highs, all contributing to a 7.32% gain that outpaced the broader market. The company’s strong financials, institutional support, and technical positioning underpin this performance, despite some cautionary signals from valuation and profit growth trends.
Investors should consider these factors in the context of the broader Pharmaceuticals & Biotechnology sector and market conditions. Granules India’s demonstrated ability to outperform the Sensex and maintain bullish momentum suggests it remains a noteworthy stock within its segment, balancing growth potential with prudent risk considerations.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
